patent infringement
Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents
Natera alleges Inivata infringes its US Patent Nos. 10,262,755 and 10,597,709, which cover cancer monitoring and molecular residual disease testing.
Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents
CareDx first sued Natera in March 2019 for infringing two of its patents, then amended the suit a year later to add a third patent.
Natera Sues Genosity for Patent Infringement Relating to ArcherDx Products
Natera claims that several Genosity products infringe its US Patent No. 10,732,220, titled "Methods for Simultaneous Amplification of Target Loci."
Federal Court Rejects ArcherDx Motion Against Natera in Patent Infringement Lawsuit
Last month, the court also ordered two separate patent lawsuits filed by Natera against ArcherDx this year to be consolidated into one.
BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute
Carlsbad, California-based BioSpyder said that HTG has repeatedly and baselessly accused it of infringing HTG's patent for quantitative nuclease protection assay and sequencing improvements.